Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist in market access consulting services to the pharmaceutical and biotech sectors.
 
The mission of MAP Patient Access Limited is to make it easier for patients to access ground-breaking medicines, devices, and diagnostics.
 
In addition to its expertise in rare and orphan diseases, it has a proven track record of helping its clients navigate increasingly complex healthcare reimbursement pathways.

Candesic Ltd

This week our team visited Imperial College Business School. Candesic is a leading strategy consultancy providing CEO level clarity with R&D level insights for over 21 years.

Dimitar Funa and Mario El Asmar gave a captivating presentation for the students including a case study workshop.

Huge thank you goes to Chris Roberys, Toby Emmerson and Dipti Thakur for helping us organise the event.

Candesic Ltd

Candesic explores benefits of revived pharmacy sector in the newest LaingBuisson HealthcareMarketsUK.

After community pharmacies played a pivotal role throughout the pandemic- could they in the future take lead over digital stores and traditional GP visits? 

Dr Michelle Tempest, Isabel Brooks & Alina Trabattoni investigate the potential of prescribers and how we only just touched the surface of what pharmacies can do.

Read the full article now.

Dr Michelle Tempest

We would like to congratulate DrDoctor on the £10m investment from YFM Equity Partners alongside Ananda Impact Ventures and 24Haymarket.

Candesic proudly supported this deal.

DrDoctor provides digital care solutions to increase communication and engagement between patients and clinicians. 

Congratulations on this next stage of development DrDoctor!

Candesic Ltd

Candesic advised on the acquisition and investment of Aesthetic Technology Ltd by Omni Partners LLP. 

We are proud to share our support on this deal that will accelerate ATL’s international expansion and product development into further medical treatment pathways. 

Candesic Ltd

Another successful year with HealthInvestor.

We salute you and thank you for announcing us as finalists for both Strategic and Transactional Consultants of the Year 2023! 
 
Since 2002 we have:

• Advised on over £25 Billion transaction value 
• Delivered over 800 projects across life sciences, health, digital and social care 
•  Enabled businesses to grow in over 38 countries around the world 

Thanks go to all our cherished clients who are all driving and striving to improve the healthcare sector for all

We couldn`t have done it without you!

Candesic Ltd

Dr Leonid Shapiro has been quoted in the newest Healthcare Business International issue.

Candesic partner comments on the multinational hospital group Ramsay Health Care and their recent UK EBITDA jump.

Click on the link to read more 
 

Dr Leonid Shapiro

Candesic partner Marc Kitten shares his point of view in the latest Healthcare Business International issue.

Marc Kitten comments on how providers can restore their reputation after facing allegations and what challenges France`s elderly care sector is currently facing.
 

Click on the link to subscribe & read the article.

Marc Kitten

Candesic is shining a spotlight on women`s health.
 
Michelle Tempest has been quoted in the latest LaingBuisson issue in an article by Hamid Yunis.

Michelle comments on attitudes towards women`s health, the difficult route of female entrepreneurs and how a jointed investment climate can change that.
 
Click on the link to read the full article.

Dr Michelle Tempest

Candesic is starting 2023 with apparence at IPEM Cannes conference where we will be discussing upcoming opportunities and challenges.

Meet us in Cannes, France Jan 23-25.

See you there! 

Candesic Ltd

Season’s greetings and holiday wishes for the new year from the very merry team at Candesic.

We are wishing you & your family all the light, warmth and joy during this time.

Merry Christmas! 

Candesic Ltd

Healthcare Business International quoted Candesic partner Marc Kitten in the latest December issue. 

Marc Kitten comments on how the hospitals in France be affected by the tiny statutory health insurer (#SHI) tariff rises.

To read more, click the link above.

Marc Kitten

Candesic partner Dr Leonid Shapiro shares his view on private equity in healthcare for 2023. He comments on the future of private equity in the possible recession.

Click on the link to read more.

Dr Leonid Shapiro

Partner Dr Michelle Tempest at the Royal Society of Medicine discussing all things digital, healthcare and robots.

The Royal Society of Medicine provides continuing medical education in the UK and Candesic is thrilled to be a part of the discussion.

Dr Michelle Tempest

Michelle Tempest look at doctors attitudes towards IT and explore if the holy grail of connectivity and personalised health can finally come to fruition.

With patient data potential to be 10-15 times more valuable to hackers than credit card data, the NHS is vulnerable to cyber attacks.

Thanks to Laing Buisson for publishing.

Read the full article below.

Dr Michelle Tempest

U.K.-based gynaecological health startup Daye, which is known for having invented the CBD tampon that is now used by over 60,000 women in the U.K., has completed a $11.5 million funding round. Candesic's Dr Michelle Tempest has also invested in this latest successful Series A funding round.

Dr Michelle Tempest

Candesic`s partner Dr Leonid Shapiro was quoted in the latest Healthcare Business International. 

He advise on the UK’s largest chain varicose vein treatment provider Veincentre which prides itself on having improved access to the varicose vein treatment and alleviated the burden on the NHS.

Dr Leonid Shapiro

McDermott Will & Emery`s life sciences and healthcare event, hosted by Hamid Yunis and Sharon Lamb showcased inclusion, diversity and friendship.

Our partner Michelle Tempest spoke about topics close to her heart such as behavioural health and female health.

On the photo Michelle along side Richard Banks, Angela Spang and Jessica Ennis-Hill take part in a "female health and fertility fireside" chat.

Candesic is proud to be a part of this important panel discussion.

Thank you to all the investors, operators and advisors for their participation that day!

Dr Michelle Tempest

We are proud to announce Candesic`s support of Three Hills Capital Partners in taking one of the UK largest and most respected social care provider CareTech private.

"We really appreciate Candesic`s support throughout the process. Their deep expertise in clinical and social care brought head and heart to the entire deal process." - Bilal Tahir, THCP

We would like to wish all the best to the team for future years!

https://www.reuters.com/markets/europe/britains-caretech-agrees-co-founders-11-bln-buyout-deal-2022-06-27/

Candesic Ltd

The Boom in Bacteria!

Candesic breaks down the newest potential addition to the blockbuster biologics market- live biotherapeutic products. Michelle Tempest and Isabel Brooks deep dive into how our body’s bacteria have inspired a new class of drug and investments for Pharma, PE and VC.

Thanks to Laing Buisson for publishing.

Read the full article below.

Dr Michelle Tempest

Yesterday we attended the inaugural lecture of the UCL Global Business School for Health, with Jeremy Hunt, former Health Secretary as keynote speaker.

UCL Global Business School for Health is the world's first business school dedicated to developing healthcare leaders and biotech entrepreneurs.

It's time to elevate the global impact of healthcare delivery!
 
Candesic congratulates the GBSH for their first anniversary, welcomes this great initiative for the health community and looks forward to accompanying the world's first business school dedicated to health.

Candesic Ltd

Today you can find us at the Imperial College Business School Careers Fair from 12:00 to 15:00.

We are looking to speak to bright minds who are looking for a career in healthcare and consulting. Our Candesic Team is here to answer your questions and guide you.

Please come and say hi to Floris Wentholt, Dimitar Funa & Dipti Thakur and find more about us! 

Candesic Ltd

It is our pleasure to announce that we are expanding our business with a new office location!

Candesic is now located at 14 Waterloo Place, London SW1Y 4AR.

Our decision was made after a lengthy search for a new office location that could meet our current and future needs and we look forward to making it our new home.

We would like to express our continued gratitude and sincere thanks for all the support and cooperation you have given us over the past years.

If you have any questions please feel free to contact us at any time.

We look forward to your visit at our new office!

Candesic Ltd

Next week, Marc Kitten our partner will join the IPEM conference in Cannes.

The largest European private capital conference will take place at the Palais des Festivals from 20th to 22nd of September.

Candesic is an award winning boutique consultancy providing due diligence and strategic advice to investors globally.

It is a pleasure for us to be back at IPEM and we look forward to meeting you there!

Candesic Ltd

We are excited to announce the arrival of our new team members:
Kilian Rupp, Dr Niam Arora, Denis Tomanov, Arnaud Plantenga, Francisco Javier Garcia Perez, Shayan Indrees, Dr Nicolas Correa de Calixto, Alessia Valteroni, Christopher Nassen, Natalie Nordbruch Palma.

You all bring a unique perspective and background to our team, and we can’t wait to see what you’ll do with it.

Always feel free to ask us for help — we’re here to support you.

Congratulations on taking the next step in your career!

Candesic Ltd

e-Prescribing has the potential to improve patient safety and reduce provider costs. It has been identified by the NHS as a key plank in its digital transformation programme. But implementation is not without its pitfalls and healthtech companies will need to do more than produce sophisticated algorithms to get a foothold in the emerging market, explain Candesic’s Dr Joe Taylor and Seth Howes.

Dr Joe Taylor & Seth Howes

Candesic's Partner, Marc Kitten, has been quoted in the FinTech Magazine. He commented "the merger and acquisitions boom is a natural progression of industry growth".

To read more, click the link above.

Marc Kitten

Dr Leonid Shapiro, managing partner, Dr Michelle Tempest, partner and Phil Carrivick, manager, at Candesic compare how different European countries approach care for People with Intellectual Disabilities (PWID) and investigate whether an increase in the market share of independent provision in Ireland will raise political questions around the commercialisation of care. Or will the focus remain on driving up clinical standards, irrespective of operator ownership?

Dr Leonid Shapiro & Dr Michelle Tempest & Phil Carrivick

Candesic's Marc Kitten was quoted in the Healthcare Business International. He commented on the international expansion of Vivalto Sante, the third largest for-profit hospital group in France.

Marc Kitten

Hot off the press: 'Tomorrow in the Making' an article about immersive healthcare training. I absolutely love new technology and this article aims to inspire operators be creative in the way they train their health and care staff and to help investors match up with businesses. It's such an honour to teach and train the next generation of carers and to make continued professional development more fun and interactive. Blessed to have interviewed some leaders in the field. Looking forward to hearing the feedback. Thanks for publishing LaingBuisson.

Dr Michelle Tempest & Andrew Tan

It is an honour to announce that Candesic won "Consultants of the year - Strategic" at the HealthInvestor UK Awards 2022.

When asked about what set Candesic apart, judges replied:

Candesic continue to deliver exceptional support to their clients, offering breadth and depth in everything they do.

What stands out is the depth of experience and capability of Candesic's team, and the excellence of its work both nationally and internationally.

Candesic have particularly enjoyed helping clients disrupt markets, improve clinical outcomes and the person-centred experience this year. Another strong year of performance.

Congratulations to all the finalists and a special thank you to HealthInvestor UK for hosting an incredible evening.

Candesic Ltd

goetzpartners has invited Dr Leonid Shapiro to the COMPASS Symposium 2022, co-hosted by NTT DATA DACH and Baker McKenzie Deutschland.

Leonid gave his keynote speech on “How Digital Health will shape future healthcare delivery” in Munich.

Candesic Ltd

Candesic’s Joe Taylor takes on the hot topic of #implantables. Many of you will know that Joe has the "implantable super power" of paying with his hand and here discusses how such technology is disrupting healthcare. Hat tip to Anna Luisa Schaffgotsch at Impli Limited.

Read our article in the latest HealthcareMarkets UK issue published by LaingBuisson.

Dr Joe Taylor

Dr Michelle Tempest, Partner and George Holden from Candesic are excited to share their thoughts on ‘digital clinical trials’.
The silver lining of Covid19 has been to show the power of working together to collect real world evidence - special thanks to all people (patients and NHS staff) involved in the REACT study. This article deep dives into some of the companies who are going global to recruit people and improving the capability of trial data to have diversity. We believe the success of digital clinical trials relies upon the coming together of so many groups of people and hence we call this brave new market - mission possible . Thanks to the people mentioned here ..... aware there are many more. 

Thanks @LaingBuisson for publishing it in @healthcaremarkets

@Cmed @BoldHealth @VineHealth @Novos @uMed @DataTrial @edge @MAC @HUMA @uMotif @Ergomed @cisiv @aparito @LindusHealth @Clinpal @Instem @IXICO @PatientKnowBest @FindMeCure @PharmaSeal @TrialBee @neucruit @Evident

#ClinicalTrials #investment #digital #VC #PE #NHS #diversity 
 

Dr Michelle Tempest & George Holden

Candesic acts as the commercial advisor to Palatine Private Equity in the acquisition of Real Regulatory, specialising in European regulatory affairs, quality systems and compliance for medical products.

Candesic Ltd

Post pandemic the ONS highlight a decrease in unemployment, which is good news. But what is the impact on the health and care sector?
Here Candesic discuss some #staffing analysis and highlight how it will take ‘working together’ - across public and private – insourcing, outsourcing, bank staff and agency staff. 
Care staff are key. Yet we have not trained enough staff to meet demand. The issue is acute on chronic.
Candesic are here to help – NHS, independent, charity, investors and start-ups to help problem solve.

#Staffing #NHS #CovidImpact #Agency
 

Dr Leonid Shapiro & Dr Christopher Cassar & Michael Tate

Candesic was pleased to provide commercial due diligence support to Charme Capital Partners in their acquisition of Prism Healthcare.

Our team at Candesic continues to work with outsourced providers of medical equipment and those investing in this active sector.

Candesic Ltd

We are delighted to announce Candesic is a finalist in the Commercial Due Diligence Provider of the Year category at the Real Deals Private Equity Awards 2022!

Candesic Ltd

We are delighted to announce Candesic has been shortlisted as finalist for "Consultants of the Year - Strategic" and "Consultants of the Year - Transactional" at the HealthInvestor UK Awards 2022. 

Candesic Ltd

Dr Gary Crotaz's first book launch was hosted at our Haymarket office. Join us in this 6-week mindset journey and let us know how you get on!

Candesic Ltd

Home health testing technology has come a long way in recent years and, driven in part by the pandemic, is set to be worth $8.15bn by 2030. Dr Michelle Tempest and Alina Trabattoni of Candesic examine the exponential growth and, given the right investment, the democratisation of healthcare it could unleash globally.

Dr Michelle Tempest & Alina Trabattoni

Candesic team at Arab Health Exhibition 2022

Candesic Ltd

Candesic's Dr Leonid Shapiro was quoted in the Healthcare Business International. He commented on the acquisition of Voyage Care by Wren House Infrastructure. Voyage Care is the UK’s largest provider of support for people with learning disabilities by revenue. 

Dr Leonid Shapiro

Candesic's analysts identified a gap in the mental healthcare market, where hospital beds for teenagers have fallen by a fifth in the last 5 years despite rising demand. In an article from the Financial Times, Dr Michelle Tempest explains the relationship between staff shortages and such unusual dynamics.

Dr Michelle Tempest

In a Candesic analysis for the Financial Times, our consultants found that more hip and knee replacements were delivered in private health facilities than NHS hospitals last year for the first time since the 1960s and 1970s. 

Dr Michelle Tempest

Financial Times spoke to Candesic's Dr Leonid Shapiro to get some insights about the real value of a three-month deal struck between NHS England and a group of 10 private healthcare providers, which is set to support NHS patients amid rising staff absences and the spread of the Omicron variant. 

Dr Leonid Shapiro

Omicron and elective care lists have something in common – both are growing out of control. Here Candesic discuss how the entire healthcare system will have to work together to get elective care back on track. Independent providers are currently delivering more elective hip and knee replacement surgery than the entire NHS. As the NHS slows down even further due to staff shortages (Omicron related), elective lists are elongating further. 

 

Dr Leonid Shapiro & Dr Michelle Tempest & Fabio Ruffinoni

Candesic's Dr Leonid Shapiro was quoted in the Healthcare Business International. He commented about the Covid patients treated in the private sector, and how it could be related to the NHS to some extent.

Dr Leonid Shapiro

Candesic's Dr Leonid Shapiro has commented on the UK social care reform in the HBI Intelligence. 

Dr Leonid Shapiro

We’re thrilled to have won the LaingBuisson’s Management Consultant Award! Thank you LaingBuisson for recognising our work.

Well done to our amazing Candesic team! 

The judges said: "Candesic's commitment to stakeholders and their wider community over the pandemic and as documented in this submission is truly inspirational. They should be particularly commended for their support for A level students.

Candesic Ltd

A new generation of highly predictive biomarkers are being developed and launched to revolutionise the diagnosis and prognosis of cancer. Candesic’s Dr Chris Cassar and Marc Kitten examine the potential impact this will have on different elements of the health service and how they can prepare for the coming changes.

Marc Kitten & Dr Christopher Cassar

Candesic' analysis of hip and knee replacements have been quoted in the Financial Times.

Dr Michelle Tempest

Candesic's Dr Joe Taylor writes about electric vehicles's untapped healthcare potential. From checking whether your hands are shaking to noticing weight changes, future software upgrades to cars could turn them into effective state-of-the-art diagnostic laboratories.

Dr Joe Taylor

The children’s services sector is primed for further growth. Dr Joe Taylor, head of the North, and Dr Michelle Tempest, partner, of Candesic, examine the opportunities the sector has to offer.

Dr Michelle Tempest & Dr Joe Taylor

The Candesic team is delighted to share news that we have been recognised as Commercial Due Diligence providers of 2021 in the private equity awards. Supporting our clients invest in, grow and improve healthcare, lifesciences and technology organisations is our shared mission. Congratulations to all the other finalists and winners at the awards. We look forward to working together over the next year. And thank you to everyone of our clients who have put their trust in our team.

Candesic Ltd

Congratulations to NorthEdge and Meet Recruitment as they start their journey working together in life sciences and recruitment. Candesic was pleased to provide commercial due diligence support.

Our team at Candesic continues to work with outsourced providers in life sciences and those investing in this active sector.

Over the past five years Candesic has become the foremost commercial diligence and strategy firm for life sciences investors.

Candesic Ltd

We are delighted to announce Candesic is a finalist in the Management Consultant category at the LaingBuisson Awards 2021!

Candesic Ltd

Candesic’s Senior Advisor, Sir Stephen Bubb, articulated the challenges facing reform of care for people with Learning Disabilities and others in need of long-term support. He was speaking on the BBC Radio 4’s flagship news, the Today Programme where he argued that funding reform was required to ensure individual care needs were put at the centre of commissioning decisions. 

Sir Stephen Bubb

Candesic is immensely proud of Valerie Adjei, our Candesic Scholar 2020 - 21, who's place at medschool at Brighton and Sussex Medical School was confirmed today. Valerie has made a fantastic contribution to our team over the past year, and we wish her all the very best as she trains to become part of what we are sure will be a great next generation of doctors. The Candesic team hopes Valerie's experience inspires others whose path to working in healthcare takes a few twists and turns to keep enthusiastic about the opportunities ahead.

Candesic Ltd

Candesic's Dr Leonid Shapiro has commented on the Bupa's M&A strategy in the HBI Intelligence. 

Dr Leonid Shapiro

Candesic's Dr Leonid Shapiro has commented on hospitals mergers and acquisitions in the HBI Intelligence. 

Dr Leonid Shapiro

We are delighted to announce Candesic is a finalist in both categories: "Consultants of the Year - Strategic" and "Consultants of the Year - Transactional" at the HealthInvestor UK Awards 2021!

Candesic Ltd

As the UK hunkered down for its first Covid lockdown last April, Candesic’s Dr Joe Taylor raised the prospect that immunity passports could pave the way back to some semblance of normality. More than a year later and with a vaccination programme in full swing, he revisits an idea that looks set become a firm feature of post-pandemic reality. 

Read this article published in LaingBuisson.

Dr Joe Taylor

We are delighted to announce Candesic is a finalist in the Commercial Due Diligence Provider of the Year category at the Real Deals Private Equity Awards 2021!

Candesic Ltd

Dr Joe Taylor explores the connections between nutritional habits and mood disorders using a double-bling randomised control trial, as part of his research group at the University of Oxford.

Candesic Ltd

Case management companies are a vital source of care coordination, helping to resolve claims between solicitors and insurers and access bespoke care packages for rehabilitation at a time when families are coping with an injury. Dr Kristoffer Kenttä, engagement manager at Candesic and Dr Michelle Tempest, partner at Candesic, provide insights into this niche market.

Dr Michelle Tempest & Dr Kristoffer Kentta

An insightful article from the New York Times places women at the epicenter of the future of healthcare. Candesic’s Dr Michelle Tempest explains how gender inequality historically affected drug trials.

Is ‘Femtech’ an increasingly important segment of the healthcare market? Read the full article to find out.

Dr Michelle Tempest

Candesic's Leonid Shapiro explains the logic behind the sale of large groups of UK care homes in an article from Healthcare Business International.

Candesic Ltd

Candesic's Marc Kitten gives insights on how Covid-19 has affected performance of European care home groups Korian and Orpea, in an article from Healthcare Business International.

Candesic Ltd

Candesic's Dr Michelle Tempest has been quoted in the Financial Times. 

Cleveland Clinic, the US based healthcare group, is to employ its own doctors when it opens its first British hospital later this year. Michelle commented Cleveland’s decision to employ its own doctors marked a “fundamental shift” for private healthcare in the UK, which has suffered a long-running shortage of doctors.

Dr Michelle Tempest

The global market for female-oriented health technology is both consumer-facing and underserved, making it ideally placed for roll-up investments while improving health outcomes. Dr Michelle Tempest and Alina Trabattoni of Candesic, examine the enormous pool of untapped demand set to send FemTech on a journey of exponential growth.

Dr Michelle Tempest & Alina Trabattoni

Candesic's Dr Leonid Shapiro has been quoted in the Financial Times.

"(The) occupancy rates were about 10 per cent below usual levels and this would make many homes unprofitable, particularly with the increased costs of personal protective equipment and insurance."

Dr Leonid Shapiro

Candesic has been quoted in the Healthcare Business International.

"As healthcare becomes ever more personalised it’s impacting specialised markets, such as orthopaedics. This piece, authored by Alina Trabattoni, Dr Kristoffer Kentta, and Dr Leonid Shapiro of health and social care consultancy Candesic, reviews how things are evolving in this pan-EU market after speaking to implant manufacturers, surgeons and patients, and reviewing clinical and patient recorded outcomes."

Dr Leonid Shapiro & Dr Kristoffer Kentta & Alina Trabattoni

Candesic's Dr Michelle Tempest has been quoted in the Financial Times.

"The NHS remains keen to work with the private sector as it can provide beds and theatres at a time when hospitals have lost capacity because of staff absenteeism and the need to observe social distancing, which has reduced the number of beds in use."
 

Dr Michelle Tempest

For all those wanting to beat the blues before Christmas and get some of Candesic’s clear thinking in these chaotic times – do take a moment to read an article by Candesic's Dr Michelle Tempest in this month’s LaingBuisson asking if our brains can be hacked? She looks into investor spending on mental health and devices, and also charts some of the emerging players. As we marvel at the successes in the healthcare sector, there is hope in these times of despair. We need the coming together of investors, researchers, innovators, operators and leaders to all prepare for 2021 and beyond. The entire Candesic team wish you all a festive and safe time.

Dr Michelle Tempest

Jamie Towner s our alumni and part of the Oxford COVID Vaccine Trial Group at the University of Oxford. Well done on the vaccine trial, Jamie. We are all so proud of you!

Candesic Ltd

The patchwork of regulation governing IVF treatment in Europe could be seen as a significant barrier to IVF providers looking to build pan-European brands, but these same variations are also driving a surge in cross-border treatment. Candesic partner, Marc Kitten, and analyst, Dr Nigel De Melo, discuss how consolidation in what remains a fragmented market could help drive safer and more accessible IVF services.

Marc Kitten

Candesic's Dr Michelle Tempest was the panelist at "Best Practices: Scaling in Healthtech", hosted by The Healthtech Exchange. Michelle has been joined by other panelists including Gary Mudie of Babylon Health, Hussein Kanji of Hoxton Ventures, Robbie Hughes CEO of Lumeon, Peter Ward CEO of Humanity, Stuart Grey of Scott Logic, Kolvin Stone of Fox Williams and Jonathan Selby Founder of The Healthtech Exchange.

Candesic Ltd

Candesic's Dr Michelle Tempest has been featured as the inspiring leaders in an article published by the RSA Group. Michelle shares her views on what it takes to be a good leader and how her background as a medical doctor was a great test of personal integrity and resilience

Dr Michelle Tempest

Can personalised medicine be used in mental health services?

Candesic's Dr Michelle Tempest shared her knowledge at a panel from the Royal Society of Medicine, providing an in-depth insight into how digital platforms can promote and enable personalised mental health service provision from both patient and clinician perspectives.

Candesic Ltd

Mediq, the Top European medicalised homecare player in 13 countries worth c. €1.2bn is up for sale.

Candesic's Marc Kitten spoke to Healthcare Business International about this transaction and its potential bidders.
 

Candesic Ltd

Candesic's Dr Michelle Tempest speaks to the Financial Times about the need for investment interest in UK children's services.

“Investors need to prove they can deliver the quality of services that children deserve."

Candesic Ltd

Health data has the potential to revolutionise care, and this has come to the fore during the pandemic.

Candesic Ltd

During a pandemic, how is health data used by GP practices and hospital trusts to improve patient management, care and experience? Dr Michelle Tempest spoke to GM Medical Journal about the benefit of having access to patients' treatments and long-term conditions.

Candesic Ltd

We are delighted to announce Candesic is a finalist in the Management Consultant category at the LaingBuisson Awards 2020!

Candesic Ltd

Candesic is proud to announce our role as commercial adviser to Morphosis Capital Fund I on its significant investment in Medima Health, a Bucharest-based medical clinic chain specialised in imaging and radiology.

Candesic Ltd

As technology advances, patient transport has the potential to move from traditional ambulance and standard taxi services to far more sophisticated yet cost effective mobile health and ‘back-home’ provision, as Dr Joe Taylor and Luke Crocker from Candesic.

Dr Joe Taylor

Candesic supports Marcol backed HealthHero's acquisition of German telehealth operator Fernarzt.

Candesic Ltd

Medical Communications is a hot topic in today’s market, and our team at Candesic is delighted to have supported Integrated Medhealth Communication (IMC) through CDD of their first acquisition, Porterhouse Medical Group. We know the coming months will be a busy time for investors seeking platform opportunities in the Medical Affairs space, and Candesic is here to help navigate these waters having built our expertise in the second though projects on Blue Latitude, Carling, Envision, Fishawack, IMC, Lucid, Signature, Xendo, among many others. 

Candesic Ltd

In the UK and across the globe, cancer care has been on hold as health systems struggle with the immediate challenge of Covid-19. As services take the first tentative steps towards reopening, Dr Michelle Tempest, Partner at Candesic and Dr Joe Taylor, Principal at Candesic, examine what measures need to be put in place to ensure safe and timely treatment for patients.

Dr Michelle Tempest & Dr Joe Taylor

Candesic's Dr Michelle Tempest has been invited to be the panelist at the European Healthcare Private Equity Symposium organised by McDermott Will & Emery. Where do the opportunities exist in this ever-changing world? 

Dr Michelle Tempest

The Candesic team published in this month's LaingBuisson Healthcare Markets Journal about the digital disruption occurred in the primary care sector due to Covid-19.

Dr Thuvarahan Amuthalingam & Dr Michelle Tempest & James Towner

Candesic's Dr Leonid Shapiro commented about the recovering of care homes after COVID-19 in the Financial Times.

Dr Leonid Shapiro

Candesic's Dr Leonid Shapiro suggested some solutions how we might solve the coronavirus problem in care homes.

Dr Leonid Shapiro

Candesic's Dr Joe Taylor examines the potential of "immunity passports" a key to the lockdown in a recent article in LaingBuisson.

Dr Joe Taylor

Candesic's Dr Leonid Shapiro researched latest data from the Office for National Statistics and other sources to provide more detail of COVID-19 related deaths. Our analysis has been quoted in the LaingBuisson featured article.

Dr Leonid Shapiro

Candesic's Dr Leonid Shapiro's analysis on the underreporting of COVID deaths in care homes has been quoted in the Healthcare Business International. 

Dr Leonid Shapiro

Candesic's Dr Leonid Shapiro has done a detailed analysis of ONS data which shows the large variation of the burden of COVID-19 on care home residents.

Dr Leonid Shapiro

Candesic's article on LinkedIn sheds light on unreported deaths related to COVID-19 in England. 

Dr Leonid Shapiro

Candesic's answers about the COVID-19's impact on care homes have been reported by the BBC. 

Candesic Ltd

The true death toll from coronavirus in care homes in England and Wales may be as high as 6,000. Candesic has advised the Financial Times that the estimate is far higher than ministers have acknowledged, because it includes people who have died in care homes or their own homes but whose deaths were not attributed to Covid-19 - in part because almost none were tested for the disease.

Candesic Ltd

Dr Leonid Shapiro from Candesic advised the Healthcare Business International "we are expecting a jump in the private market post COVID-19 as people who were holding back on electives return. And the NHS may still be dealing with COVID-19 for a period after restrictions are lifted elsewhere, so might need to outsource more work".

Dr Leonid Shapiro

Candesic speaks to the Financial Times on the impact of COVID-19 on the UK care homes.

Candesic Ltd

As Artificial Intelligence takes over our economies, could we risk lacking the capacity to make our own independent decision or to question those provided by computers? Candesic's Dr Michelle Tempest writes for the Psychologies Magazine about the dilemma of outsourcing thinking.

Dr Michelle Tempest

Our lives have been transformed by COVID-19, and in the short term, they will change still yet. But what will happen after this pandemic is over? Will life go back to the way it was? Dr Leonid Shapiro, managing partner at Candesic, looks beyond the immediate crisis gripping health systems to explore the impact the outbreak might have on the NHS and social care in the longer term.

Dr Leonid Shapiro

Candesic speaks to the Financial Times on the availability of tests for COVID-19.

Candesic Ltd

Candesic's Dr Michelle Tempest interviews with international news channel FRANCE 24 on COVID-19 and the related UK Government action, preparedness of the NHS, private sector, as well as the theory behind herd immunity.

Dr Michelle Tempest

As the Financial Times asks whether the UK needs to step up its testing regime for coronavirus and find ways of increasing the number of critical care beds the NHS can call on during the epidemic, Candesic's Dr Michelle Tempest highlights that many private hospitals do not have intensive care units and employ doctors who also work in the NHS, potentially leading to a future battle for trained clinical carers between the two sectors.

Dr Michelle Tempest

Candesic is delighted to be shortlisted as a finalist by both the highly regarded HealthInvestor UK Awards 2020 in the Strategic and Transactional categories, and The Private Equity Awards 2020 hosted by Real Deals in the Advisory Awards category.

Candesic Ltd

Candesic's Dr Michelle Tempest speaks to the Financial Times on Britain's biggest mental healthcare provider, the Priory Group, which is set to be sold for c.£1bn.

Dr Michelle Tempest

Candesic is proud to announce our role as Adviser to LDC on its significant investment in Ashtons Hospital Pharmacy Services, a leading provider of medicine management solutions to the UK independent healthcare sector.

Candesic Ltd

Candesic's Dr Michelle Tempest was quoted in the article in the Healthcare Business International.

Dr Michelle Tempest

Candesic is proud to announce our role as Adviser to Australia's The Citadel Group on its acquisition of Wellbeing Software, a leading provider of radiology and maternity software in the UK for £103 million.

Candesic Ltd

Candesic is pleased to announce our role as Adviser to Gulf Capital on its US$40M investment in Vezeeta.com, the Middle East and Africa's leading digital health care platform.

Candesic Ltd

Demand for mental health services is rising across the developed world, but with larger populations, greater competition for
resources, higher levels of isolation and increased stress, big cities are feeling the pressure most acutely. Candesic’s Dr Michelle
Tempest takes a deep dive into the current state of London’s mental health provision to find out how the independent sector could
help meet the ever widening gulf between demand and supply.

Dr Michelle Tempest

We are very proud to be named one of the UK's Leading Management Consultants in 2020 in Healthcare & Life Sciences - improving care and life sciences with passion and integrity. 

Candesic Ltd

Candesic acts as Adviser to Gulf Capital on its US$100m acquisition of IVI-RMA's Middle Eastern IVF fertility operation.

Candesic Ltd

Candesic's Dr Joe Taylor and Dr Michelle Tempest consider how changes in staffing roles and technological innovation can keep people in healthcare roles.

Dr Michelle Tempest & Dr Joe Taylor

Marina Gilic and Dr Leonid Shapiro discuss the key differences between IVF in the Middle East and in Europe and what this means for investors and operators alike.

Dr Leonid Shapiro & Marina Gilic

Candesic has been quoted in the Financial Times on US Corporations expand across NHS mental healthcare. 

Dr Michelle Tempest

Marina Gilic has been invited to speak at the European Leadership Summit organised by the Healthcare Businesswomen's Association. 

Candesic Ltd

Dr Michelle Tempest, Partner at Candesic and Barbara Pusca, Principal at AlphaSkill, discuss how the complex digital world holds the potential of sustained returns for investors.

Dr Michelle Tempest & Barbara Pusca

Dr Michelle Tempest was invited to be the panel at the Healthcare Private Equity Leadership Forum organised by McDermott Will & Emery.

Dr Michelle Tempest

Candesic enjoyed sharing our data focussed research on the regulatory challenges across care provision in the UK. Dr Joe Taylor was the keynote speaker at the HealthInvestor Insights Series Manchester Conference. Understanding the implications of regulation for providers better enables us to drive up care standards.

Dr Joe Taylor

We are proud to be finalists in the LaingBuisson awards 2019 for Management Consultant.

It is a tribute to our client's trust and to our outstanding team, passionately dedicated to improving healthcare.

Dr Leonid Shapiro

Candesic advised a real estate investor on the development of a major property company with Résidence Mobicap in France. 

The project undertakes the construction of a large portfolio of dedicated rental housing suitable for people with #physicaldisabilities. Proud to fulfil our mission to make a meaningful difference to society. 

Marc Kitten

Candesic at the WIRED conference – reviewing AI and cobots with Dr Michelle Tempest

Dr Michelle Tempest

The US leads the trend: physicians are turning to PE for injections of capital, branded chains are competing with traditional secondary care offering, clinical services are expanding to more patients through recruiting and automatising, big tech platforms are leveraging their oligopoly (Deepmind, Apple) removing barriers to interoperability. 

The key in digital healthcare development remains to adopt clinical relevance alongside academic rigour. The UK is experiencing changes in all sectors of the offering: examples abound, like Medtronic (getting patients off ventilator), Cognitant (3D graphics and VR to better exchange with patients), Babylon or Dr Care anywhere for teleconsultations or home diagnostics.

Dr Michelle Tempest

Candesic were finalists at the HealthInvestor awards in two categories - strategy and transactional consultants of the year.

Candesic Ltd

@PE_Insights. The Madrid audience shared the optimism of the panel members regarding the mid term #outlook for #privateequity #iberia. The market remains constrained by the limited supply of transactionable SMEs but LPs see ongoing above average mid-term performance in Europe.

Marc Kitten

Tikehau Capital, through its pan-European growth equity fund, is investing £23m (c. €26m) in Medtrade Products Limited, the UK-based technology-led medical device company.

Medtrade is a developer of medical device products with a successful track record in the advanced woundcare and haemostat markets. Founded in 1999 and based in Crewe, United Kingdom, Medtrade has a leading in-house development expertise, rapid product development process and long-standing relationships with global blue-chip companies

Marc Kitten

Nadine Badra

Dr Michelle Tempest rewarded with the prestigious Business Partner of the Year & Most Influential Woman in Healthcare - UK by Corporate America Today

Dr Michelle Tempest

Marc Kitten

Congratulations to  General Atlantic on their investment in Doctolib. Doctolib is a leading Pan-European #digitalhealth player founded in 2013. Historically backed by #Bpifrance, #Eurazeo, #Kernel, #Accel, as well as individuals, Doctolib is now looking roll-out its market leading #teleconsultation service, further improving its products, and reaching into new geographies under General Atlantic’s investment.

#digitaltransformation #digitalhealthcare #teleconsultation #unicorns

Dr Leonid Shapiro & Marc Kitten & Dr Michelle Tempest

Dr Michelle Tempest chaired discussions at the RSM yesterday around integration of AI within existing models of healthcare, and in particular:

Opportunities for AI in primary care 

Ethical and regulatory perspectives of AI in healthcare 

Use of AI in drug discovery  

Application of deep learning to breast cancer screening 

Dr Michelle Tempest

Candesic's Dr Michelle Tempest has been awarded the "2019 Business Partner and most influential woman in healthcare - UK " by M&A today. 

Dr Michelle Tempest

Dr Michelle Tempest looks at mental health policy and examines the emerging market for digital based interventions. 

Dr Michelle Tempest

Candesic's Dr Michelle Tempest has been awarded the "2019 Business Partner and most influential woman in healthcare" by Lawyer International's Legal-100.

The Legal 100 - 2019  Awards exist to showcase firms and individuals that continually provide the client with an outstanding level of service, demonstrating an incredibly high degree of ability, whilst delivering the outstanding results that are synonymous with firms and individuals of this calibre.

Dr Michelle Tempest

CU MedTech presents: from Doctor to Healthcare Consultant Thursday 31st January at 17:30 -

Alternative careers in Medicine Lecture Theatre 2, CAMBRIDGE CLINICAL SCHOOL, CB2OSP

Dr. Michelle Tempest, Partner at Candesic, a leading strategy management consultancy, will uncover the myths about healthcare consulting to Cambridge University Med Tech students on 31st Jan 2019.

Candesic Ltd

Dr Michelle Tempest, Partner at Candesic, interviewed by Gill Plimmer in the FT on the wave of deals in the privatised fostering market: Opportunities to consolidate and build economies of scale as fostering businesses are resilient to political change and financial squeezes.

Dr Michelle Tempest

Candesic is proud to have been the Commercial Due Diligence Advisor for Waterland on their acquisition of Sandcastle. Sandcastle provides residential services in the North West for children who are in need of psychological support to transform their lives.

Candesic Ltd

Candesic's Dr Joe Taylor and Dr Timothy Owen are pleased to deliver lectures on the future of dementia diagnosis and treatment at the Ionian University in Corfu, Greece as part of the GeNeDis 2020 Worldwide Congress.

Dr Joe Taylor

Dr Michelle Tempest has been named as a global influencer by the Influencer Times.

Dr Michelle Tempest

Frequently viewed as a cosmetic procedure, varicose vein removal is being restricted to the point where it could soon become non-existent on the NHS except in the most severe cases. The result has been a boom in demand for treatment in the independent sector and as Dr Joe Taylor explains, high growth rates, a healthy pool of consultants and a fragmented market could present opportunities of scale. 

Dr Joe Taylor

Candesic's Managing Partner, Dr Leonid Shapiro, presented at this leading conference which gathers top Greek life science companies, investors and advisors. Leonid spoke about access to finance for life science companies and how capital can be secured to foster accelerated growth.

Dr Leonid Shapiro

Candesic was named the Winner of the Management Consultant at the LaingBuissin Awards 2018. The Award was presented to us in recognition of our outstanding services. It's not about us. We contribute, with you, to improve health and social care. 

Candesic Ltd

When it comes to digital disruption in healthcare, oncology, perhaps more than any other specialty, is changing the most. Dr Michelle Tempest and Roma Dixit discuss how big pharma is following in the footsteps of tech giants to harness the revolutionary benefits of digital. 

Dr Michelle Tempest & Roma Dixit

Sir Stephen Bubb, Senior Advisor at Candesic, commented in the Sky News about the care of people with Learning Disabilities and Autism.

Sir Stephen Bubb

Dr Michelle Tempest was quoted in the Financial Times about the outsourced health services news.

Dr Michelle Tempest

Dr Joe Taylor spoke about how providers can negotiate the changing demands on home care in Bristol. He argued that mental health had to be put at heart of home care. Subsequently he was upstaged by a robot.

Dr Joe Taylor

Aspen Healthcare, an independant healthcare organisation consisting of 9 acute care hospitals, has been sold to UAE-based NMC Healthcare.

Dr Leonid Shapiro was quoted in the article in HealthInvestor that considers what this new aquisition means for NMC.

Dr Leonid Shapiro

Dr Michelle Tempest was invited to be the speaker at the European Healthcare Private Equity Leadership Forum organised by McDermott Will & Emery. 

Dr Michelle Tempest

Dr Michelle tempest spoke about healthcare technology at the Big Tent of Ideas conference.  It was a cross party conference with fresh new ideas in each tent.

Dr Michelle Tempest

Dr Michelle Tempest and Patrick Bansch of bespoke health and social care strategy and investment consultancy Candesic get a close-up look of the private ophthalmology market to find out if the sector is ripe for disruption.

Dr Michelle Tempest & Patrick Bansch

Candesic'a Dr Michelle Tempest was quoted in the article in the Healthcare Business International.

Dr Michelle Tempest

Candesic has been awarded the "10 Most Trusted Consultant Companies 2018" by Insights Success.

Candesic Ltd

Candesic's Dr Michelle Tempest commented on how the private hospitals market has been affected by the NHS in the Financial Times.

Dr Michelle Tempest

Candesic has been awarded the "Leading Providers of the Due Diligence Services - Greater London" by AI Globalmedia Publication.

Candesic Ltd

Candesic's Dr Michelle Tempest commented on the children's care services merger in the Financial Times.

Dr Michelle Tempest

Candesic's Dr Michelle Tempest has been awarded the "2018 Influential Businesswoman Awards - Healthcare Management Consultant Consultant of the Year 2018 - UK"! 

Dr Michelle Tempest

Candesic's Dr Leonid Shapiro comments on the IVF and fertility treatment in the Healthcare Markets published by LaingBuisson.

Dr Leonid Shapiro

Candesic are delighted to win Consultants of the year - Transactional at the HealthInvestor Awards 2018. 

A double honour as last year Candesic won Consultants of the year - Strategic. 

Candesic want to THANK YOU - The care sector is built on long-term personal relationships and we really enjoy working with our clients to improve healthcare in the UK and around the globe. 

Candesic Ltd

Candesic's Dr Michelle Tempest wrote an article about Artificial Intelligence (AI) published by the Healthcare Digital.

Dr Michelle Tempest

Candesic's Dr Michelle Tempest has been invited to be the panelist at the TMT Sector Update organised by Simmons & Simmons. 

Dr Michelle Tempest

Candesic's Marc Kitten was the moderator at the Small & Mid Cap Panel Discussion at the Private Equity Insights Madrid Conference. 

Marc Kitten

Candesic is proud, honoured, and inspired to win this year's Real Deals Private Equity Awards. We are the only specialist consultancy to win this generalist award. In the last year, Candesic, 

• Worked on transactions valued over £4bn
• Served 40 clients in 10 countries
• Delivered work with our team of 25 full-time employees, one-third of whom are doctors

Candesic's focus on delivering great quality work across multiple industries stands out, and this was particularly noted for their work in the healthcare sector where they demonstrated a deep understanding of that industry in the deals conducted in 2017.

-- Prof. Scott Moeller, Director of the M&A Research Centre, Cass Business School and Real Deals PE Awards Judge

Candesic Ltd

Dr Leonid Shapiro from Candesic spoke at the Healthcare Business International Conference 2018 looking at growth and opportunities in global healthcare.

Dr Leonid Shapiro

Dr Michelle Tempest from Candesic spoke at the Healthcare Business International Conference 2018 looking at growth and opportunities in global healthcare.

Dr Michelle Tempest

Dr Michelle Tempest, partner at Candesic, and Prof Ian Goodyer, professor of Child and Adolescent Psychiatry look at the state of demand and supply and what can be done to improve access and early intervention for the young. 

Dr Michelle Tempest & Prof Ian Goodyer

Dr Leonid Shapiro from Candesic joined the Freeths Future of Care event. 

Dr Leonid Shapiro

Candesic is the finalist for the Commercial Due Diligence Provider of the Year for the Private Equity Awards 2018 organised by Real Deals.

Candesic Ltd

Congratulations to Candesic Board Member Prof Steve Smith for becoming Chairman at a large NHS Trust. 

Candesic Ltd

Candesic's Dr Nisa Aslam and Dr Joe Taylor consider the implications of the paucity of sexual health screening services and the potential for new models of sexual health management.

Dr Joe Taylor & Dr Nisa Aslam

Candesic wins "UK's Leading Management Consultants 2018", a recognition by Financial Times in partnership with Statista. 

Candesic Ltd

Dr Druin Burch from Candesic and Oxford University Hospital explores the new models of general practice emerging in the 21st century and asks whether they can prove attractive enough to boost the supply of GPs in England.

Dr Druin Burch

Candesic's Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech space.

Dr Michelle Tempest & Dr Niklas Jahn

Our Managing Director and  Founder, Dr Leonid Shapiro, has been recognised as the Sector Specialist at the HealthInvestor Power 50 Awards 2017.

Dr Leonid Shapiro

Dr Joe Taylor provided insight into regional Learning Disability markets at the HealthInvestor Midlands Focus conference in Birmingham.

Dr Joe Taylor

Candesic's Dr Joe Taylor and Dr Michelle Tempest report on the outlook for health and social care policy from the Conservatives and Labour party conferences.

Dr Michelle Tempest & Dr Joe Taylor

Dr Michelle Tempest provides insight on the rising investment in Healthcare AI and its 'unicorns' predicted future.

Dr Michelle Tempest

Dr Joe Taylor considers the implications of personalised pharmacotherapy for life sciences and healthcare.

Dr Joe Taylor

Dr Michelle Tempest and Dr Sam Winward of Candesic take a look at why AI is growing in healthcare and who to follow.

Dr Michelle Tempest

Having progressed from hospital doctor to management consultant, it is now Dr Michelle Tempest's mission to get more doctors involved in the management of healthcare to help guide positive change from within. 

Dr Michelle Tempest

Dr Michelle Tempest Partner and Dr Sham Dholakia, Candesic expert, argue that "London calling" is so much more than a song by The Clash; it has become the speed dial signature tune to international medical markets.

Dr Michelle Tempest

Dr William Watson wrote a letter on The Guardian responding to Jeremy Hunt's defence of his health policy. 

Dr William Watson

Dr Michelle Tempest commented NHS's recruitment in the Financial Times. 

Dr Michelle Tempest

Dr Michelle Tempest commented on the private hospital opportunities in the HealthInvestor.

Dr Michelle Tempest

Candesic wins "Best Health & Social Care Management Consultancy 2017" in the 2017 Greater London Enterprise Awards, hosted by SME News. 

Candesic Ltd

Dr Michelle Tempest wins: 'Business Partner of the Year 2017 - UK & Most Influential Woman in Healthcare' for Candesic, awarded by 'Female CEO Excellence Awards 2017'.

Dr Michelle Tempest

Orthopaedic procedures such as hip and knee replacements have long been the bread and butter of independent hospitals in the
UK, but changes at a local level are shifting market shares. Partner at Candesic Dr Michelle Tempest, examines the latest trends
and explores what providers can do to stay ahead of the game.

Dr Michelle Tempest

Dr Michelle Tempest comments on an article on mental health as published by Healthcare Business International.

Dr Michelle Tempest

Candesic's Dr Joe Taylor considers the implications of the UK's shortage of doctors.

Dr Joe Taylor

Dr Michelle Tempest comments on the public-private partnership models driving change in health and social care. 

Dr Michelle Tempest

Candesic won Strategy Consultants of the Year at the HealthInvestor Awards 2017. We pride ourselves on delivering CEO level clarity with R&D level insight. 

Dr Leonid Shapiro & Marc Kitten & Dr Michelle Tempest & Dr Joe Taylor

Dr Michelle Tempest and Dr Joe Taylor discuss the staffing shortage in the care sector.

Dr Michelle Tempest & Dr Joe Taylor

Marc Kitten and Dr Stewart Southey of Candesic review the latest applications of blockchain technology to healthcare and life sciences.

Marc Kitten & Dr Stewart Southey

Dr Joe Taylor appeared on Thailand's leading television network to discuss the NHS and implication of the UK General Election.

Dr Joe Taylor

Dr Michelle Tempest talks to Healthcare Business International about Digital Healthcare in the UK and how it can expand globally.

Dr Michelle Tempest

Dr Leonid Shapiro commented on Aspen, “£150m seems low but it doesn’t reflect badly on Aspen. If it ends up being a forced sale because Tenet needs cash, it’s not a bad price, but there isn’t a large number of obvious buyers so it may even go for a lower amount,”

Dr Leonid Shapiro

Is the mental health market set to go global, using click technology?

Dr Michelle Tempest

Dr Michelle Tempest and Paul Fegan researched on Acquired Brain Injury (ABI). 

Dr Michelle Tempest & Paul Fegan

Dr William Watson commented on the Guardian's article.

Dr William Watson

Dr Michelle Tempest has moderated the Psychiatry panel at the Healthcare Business International Conference 2017. 

Dr Michelle Tempest

Dr Matteo De Martino and Dr Leonid Shapiro of Candesic predict how IVF clinics will win clients and upsell services in the future.

Dr Leonid Shapiro & Dr Matteo De Martino

Dr Leonid Shapiro from Candesic commented on Mayo Clinic's plan to open hospitals in London. 

Dr Leonid Shapiro

Dr Leonid Shapiro from Candesic commented on Mitie's sale of its homecare business to Apposite Capital. 

Dr Leonid Shapiro

Dr Michelle Tempest and Dr Niklas Jahn of Candesic diagnose the investment case for the orthopaedic hip and knee joint replacement market.

Dr Michelle Tempest

Dr Michelle Tempest analyses recent transactions in the mental health sector and discusses the emerging opportunities for investors in a service that is fast coming out of the shadows.

Dr Michelle Tempest

Dr Leonid Shapiro spoke at the LaingBuisson Investing in Healthcare conference on 8 February about how branding and marketing is affecting the health and social care market. 

Dr Leonid Shapiro

Dr Michelle Tempest is quoted in the Financial Times commenting about NHS outsourcing of England’s hip and knee replacement operations.

Dr Michelle Tempest

Candesic's Dr Joe Taylor and Kate Hall consider the role physiotherapy can play in addressing the amassing challenges of health and social care faced by an ageing UK

Dr Joe Taylor

Candesic doctors Michelle Tempest and Joe Taylor consider the impact of the inexorable rise in antimicrobial resistance

Dr Michelle Tempest & Dr Joe Taylor

Dr Leonid Shapiro comments on the private equity market in the newsletter published by Nexus Corporate Finance

Dr Leonid Shapiro

Candesic exhibited at the GIANT global innovation and new technology health event in November. The conference brought together leaders from across healthcare and technology, from established pioneers to the next wave of startups. The Candesic team were on hand to discuss the means by which technology is transforming the delivery of care and enabling new ways of providing clinical services outside of hospital. 

Candesic Ltd

Candesic's Dr Joe Taylor and Dr Michelle Tempest report on the grass-roots polarisation apparent at the major party conferences. 

Dr Michelle Tempest & Dr Joe Taylor

Dr Joe Taylor considers opportunities to improve ABI services to address 21^st century challenges and opportunities in neuro-rehabilitation

Dr Joe Taylor

Dr Michelle Tempest and Patrick Bansch review the health and wellness market and consider an exciting new investment opportunity in a luxury holistic health hotel.

Dr Michelle Tempest

Dr Michelle Tempest, Miss Heidi Tempest and Dr Leonid Shapiro take a leap forwards into the brave new world of tomorrow’s tech enabled health and social care.

Dr Leonid Shapiro & Dr Michelle Tempest

Marc Kitten, Dr Joe Taylor and Floris Wentholt explore the market for CPAP in obstructive sleep apnoea (OSA)

Marc Kitten & Dr Joe Taylor

Candesic’s Dr Joe Taylor considers the journey ahead for learning disability services.

Dr Joe Taylor

Dr Leonid Shapiro looks at how the new dental contract, scheduled for implementation in 2017, is likely to change the way investors make money in dentistry

Dr Leonid Shapiro

Dr Leonid Shapiro commented on the new opportunities in real estate.

Dr Leonid Shapiro was on the panel discussion at the Healthcare Business International Conference on 26 April 2016.

Dr Leonid Shapiro

Dr Joe Taylor was invited to speak at the Browne Jacobson's Elderly Care Conference on 21 April 2016. Joe considered the future of health and social care provision for older people, providing an overview of what the future is likely to hold from both technological and service configuration outlooks. 

Dr Joe Taylor

Dr Joe Taylor reviews trends in the provision of residential services for looked after children, arguing growing demand requires innovation on the part of independent providers.

Dr Joe Taylor

Candesic’s Michelle Tempest asks if 2016 will finally be the year medtech really takes off

Dr Michelle Tempest

Dr Michelle Tempest is on the guest blog on 2020health.

Dr Michelle Tempest

Dr Michelle Tempest is on the guest blog on 2020health.

Dr Michelle Tempest

Dr Michelle Tempest is on the guest blog on 2020health.

Dr Michelle Tempest

Dr Leonid Shapiro of Candesic examines what the latest government legislation means for the social care sector.

Dr Leonid Shapiro

Candesic's analysis on social care funding.

Dr Leonid Shapiro

Candesic reviews the rapidly moving landscape within primary care and how the time is ripe for investment. 

Dr Michelle Tempest & Paul Fegan

Candesic is quoted in the Financial Times discussing healthcare tenders and integrated care.

Dr Michelle Tempest

Dr Leonid Shapiro said "Healthcare is just becoming more consumerist..."

Dr Leonid Shapiro

Dr Joe Taylor and Dr Michelle Tempest report from this year's Labour and Conservative party conferences.

Dr Michelle Tempest & Dr Joe Taylor

Dr Michelle Tempest was interviewed live by Cambridge TV about the challenges faced by Addenbrooke's Hospital and local Councils and was asked to consider the impact of the national living wage alongside the budgetary restraints.  Michelle (@DrMTempest) spoke about potential innovative solutions to such issues.

Dr Michelle Tempest

Dr Michelle Tempest gave an exclusive TV interview about Candesic's work.  She described how the Candesic team develop solutions to real life healthcare business problems with a full time employed team mixing skills from business, front line healthcare experience and academia.  The team are always recruiting the brightest and the best - so come and get involved in strategic solutions!

Candesic: CEO level clarity with R&D level insight.  

Dr Michelle Tempest

Dr Michelle Tempest commented on the Intuition Communications blog "one of the new models of private healthcare delivery might embrace an 'UberDoc' or an 'UberNurse' where mobile healthcare professionals could be summoned and paid for via an app"

Dr Michelle Tempest

Candesic's Dr Joe Taylor and Dr Leonid Shapiro consider what opportunities "medicalised" home care will bring to providers as the sector expands.

Dr Leonid Shapiro & Dr Joe Taylor

Dr Michelle Tempest was invited to speak at the LaingBuisson Private Acute Healthcare Conference on "Can private providers make NHS work profitable?"

Dr Michelle Tempest

Candesic supports AXA Real Estate and MPT REIT in Spanish private hospital acquisition.

Dr Leonid Shapiro

Dr Michelle Tempest chaired a conference on 8th September on "Benchmarking your NHS Private Patient Service". The day was a mixture of talks and group discussions, with plenty of learning about how things are done differently all around England.

Dr Michelle Tempest

Dr Leonid Shapiro from Candesic examines the confounding factors challenging the elderly care industry and how operators should navigate the troubled waters.

Dr Leonid Shapiro

Dr Joe Taylor from Candesic investigates how software can drive the integrated care agenda.

Dr Joe Taylor

Dr Leonid Shapiro discussed about how technology enabled patient empowerment will change private healthcare.

Dr Leonid Shapiro

Candesic's Dr Robert Watson and Dr Michelle Tempest discuss medical advances in cancer treatment. They explain medical terminology and how investment is vital in the global cancer race.

Dr Michelle Tempest & Dr Robert Watson

The Election is here: Dr Michelle Tempest discusses the political ramifications for investors and providers.

Dr Michelle Tempest

Marc Kitten and the Candesic team finds "The funeral care market is fragmented, providing opportunity for a consolidation play, if investors can stomach it."

Marc Kitten

Dr Leonid Shapiro from Candesic advised Tenet on the acquisition of Aspen Healthcare.

Dr Leonid Shapiro

Dr Leonid Shapiro is interviewed with Andy Burnham about Labours’ plan to cap private sector profits from the NHS.

Start Listening 8 minutes in.

Dr Leonid Shapiro

Dr Joe Taylor from Candesic considers changes in the UK fostering market and opportunities for growth in the independent provider segment.

Dr Joe Taylor

Dr Michelle Tempest was on Channel 4's documentary NHS: £2 Billion a Week and Counting.  She discussed dementia care and future financial ramifications.

Dr Michelle Tempest

Dr Michelle Tempest was on BBC Radio Cambridgeshire to discuss about Acute Hospitals. 

Dr Michelle Tempest

Dr Michelle Tempest at Candesic commented on the Financial Times "If it were a private company they would let it go bust but, given they can't, taxpayers will have to foot the bill for keeping the hospital running. Circle has effectively limited its losses to £5m but it is the NHS that will now have to pick up the pieces and decide what to do"

Dr Michelle Tempest

Dr Michelle Tempest from Candesic reviews how specialisation impacts the entire healthcare market covering everything from Circle Holdings to NHS University hospitals

Dr Michelle Tempest

Dr Leonid Shapiro at Candesic points out "A secure placement costs around a quarter of a million pounds a year and some of the private operators have quite a lot of these people, so they stand to lose a lot of revenue if this goes through"

Dr Leonid Shapiro

Dr Michelle Tempest at Candesic argues "NHS England put its own tank on the multi-coloured political lawn"

Dr Michelle Tempest

Dr Leonid Shapiro at Candesic commented "The fact that several large providers are exiting the publicly paid for home care market shows that funding is insufficient. Given that the bulk of homecare is privately provided, funding levels will have to improve dramatically. Which ever party wins the general election."

Dr Leonid Shapiro

Candesic's Dr Leonid Shapiro gave his professional opinion on Point of Care Testing (POCT) technologies.  

Dr Leonid Shapiro

Dr Michelle Tempest explains the key academic research for a successful election campaign.  With just over 100 days until the general election, political parties should move away from spin doctors to facts, data and outcomes.

Dr Michelle Tempest

Dr Michelle Tempest comments on the sudden announcement of private operator Circle withdrawing from the NHS contract of the 369-bed hospital in Cambridgeshire.

Dr Michelle Tempest

Could charging for A&E persuade people who use it unnecessarily to get help elsewhere? Candesic's Dr Leonid Shapiro gave his professional opinion on BBC Radio 4.

Dr Leonid Shapiro

Candesic's partner Dr Michelle Tempest comments on Sunniva Davies-Ro's article. Dr Tempest speculates that the document hasn't necessarily excluded private providers. "Within the conglomeration of providers that the FYFV says should work together, it's pretty ambivalent whether these would be private operators, NHS or both."

Dr Michelle Tempest

Marc Kitten and Dr Joe Taylor explore how existing software platforms and technologies could address healthcare's looming workforce crisis.

Marc Kitten & Dr Joe Taylor

Dr Leonid Shapiro and Paul Fegan of Candesic examine how intensive home care is being considered as an alternative to institutionalising people with debilitating neurological conditions. 

Dr Leonid Shapiro & Paul Fegan

Dr Joe Taylor gave his professional analysis on the injuries of Jack Bauer in the movie, 24: Live Another Day.

Dr Joe Taylor

Candesic's Dr Joe Taylor argues mHealth is not a luxury, but a necessary element of 21st century medicine for care providers.

Dr Joe Taylor

The £3.5bn special schools market is about to be transformed. But providers must ready themselves for the changes, argues Candesic's Dr Joe Taylor.

Dr Joe Taylor

David Burrowes MP, co-chair of the All Party Parliamentary Group on Complex Needs & Dual Diagnosis, and Dr Michelle Tempest of Candesic challenge health & wellbeing boards to deliver integrated addiction services.

Dr Michelle Tempest & David Burrowes MP

Dr Michelle Tempest gave her expert opinion to Financial Times.

Dr Michelle Tempest

Dr Michelle Tempest investigate how patient empowerment facilitated by the internet, is changing healthcare.

Dr Michelle Tempest

Dr Leonid Shapiro provides his expert opinion to the Financial Times

Dr Leonid Shapiro

During a ceremony attended by over 1300 health and social care leaders, Candesic won the "Best Strategy Consultancy 2014" award by HealthInvestor. When asked about what set Candesic apart, judges replied:

• "Candesic continue to impress because of their stability, deep sector knowledge and hands on approach"
• "They have a broad client base across the public, private, and not for profit sectors"
• "Healthcare specialists, Candesic are advising the pioneers in the sector, helping to define the markets and strategy of the future"
• Clients say they offer exactly what management consultants should offer: 'real grass route experience to deliver thoughtful business strategy"

Candesic Ltd

Dr Michelle Tempest reviews medical tourism trends.

Dr Michelle Tempest

Dr Michelle Tempest and Marc Kitten of Candesic consider the explosive growth in medical tourism.

Marc Kitten & Dr Michelle Tempest

The College of Emergency Medicine and Candesic delved into data on A&E attendances and found discrepancies that should be viewed an opportunity to design services fit for the future. By Dr Clifford Mann and Michelle Tempest

Dr Clifford Mann

Efforts to redirect patients away from busy A&E departments will not work, doctors have said - as a new study shows most need to be seen there.

Dr Michelle Tempest & Dr Clifford Mann

Most patients attending NHS accident and emergency departments require comprehensive treatment that could not be provided by a GP, according to study by Candesic.

Dr Michelle Tempest

NHS England's primary care co-commissioning plan could help ease pressure on accident and emergency services, a researcher behind a new College of Emergency Medicine study has claimed. 

Dr Michelle Tempest

Dr Michelle Tempest said "the treatment model for obesity needs to change. Candesic examines what can be done.

Dr Michelle Tempest

European aerospace suppliers face huge risks despite booming order books.

Antoine Gelain

Candesic's Dr Joe Taylor comments on the article: "Anyone who can offer CCGs expertise on managing their services more efficiently potentially has much to gain from this"

Dr Joe Taylor

An invesigation of the implications of the largest reform of the Irish healthcare system since Irelands's independence.

Dr Leonid Shapiro

Dr Joe Taylor comments on Thomas's article. Dementia care in England is suffering from a serious case of underinvestment. Who is to blame, asks Daniel Thomas

Dr Joe Taylor

Dr Joe Taylor examines the continuous insulin infusion opportunity in diabetes

Dr Joe Taylor

Big data can fuel opportunities for providers and investors, says Dr Joe Taylor, but it's not without its added burdens and potential pitfalls.

Dr Joe Taylor

Dr Joe Taylor and Dr Leonid Shapiro argue that the state of the plasma fractionation industry is expected to fundamentally change in the future

Dr Leonid Shapiro & Dr Joe Taylor

Dr Druin Burch and Dr Leonid Shapiro explore how prime contracting is overhauling the NHS ecosystem.

Dr Leonid Shapiro & Dr Druin Burch

Candesic examines the 3D printing opportunity in healthcare

Marc Kitten

The Candesic team examines trends in dementia care

Dr Michelle Tempest & Dr Joe Taylor

Dr Leonid Shapiro discusses how the current system is not up to the job of delivering modern medicine.

Dr Leonid Shapiro

Antoine Gelain discusses the uncertainty in the defence contracting industry.

Antoine Gelain

Dr Leonid Shapiro and Loic Llamas examine how the line between private and NHS fertility clinics is blurring.

Dr Leonid Shapiro

Marc Kitten and Alice Gaudillat consider investment opportunities across Europe.

Marc Kitten

Dr Leonid Shapiro investigates the future of the UK fostering market.

Dr Leonid Shapiro